Brought to you by 
VidaMed completes IPO; nets over $20 million
13 Jul 1999
Executive Summary
VidaMed (devices for the treatment of benign prostatic hyperplasia) has netted about $18 million in an IPO of 3.1 million shares at $6.50 per share. When the offering was registered in May, the company intended to sell 2.5 million share at $10 each.
Deal Industry
- Medical Devices
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
VidaMed completes IPO; nets over $20 million
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice